Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography-Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos) - Summary - MDSpire
Advertisement
Clinical Assessment of a New Repositionable Plastic Stent for Endosonography-Guided Hepaticogastrostomy With or Without Antegrade Stenting (Including Videos)
To evaluate the efficacy and safety of a novel repositionable plastic stent (PS) for endosonography-guided hepaticogastrostomy (EUS-HGS) in patients with malignant or benign biliary disease.
Approach:
Patient Selection: Included patients undergoing EUS-HGS for malignant biliary obstruction or benign biliary disease, excluding those under 20 years, those who underwent EUS-HGS with an initial plan for placement of a metal stent, those in whom puncture was deemed difficult due to insufficient dilation of the intrahepatic bile duct on EUS evaluation, and those who underwent EUS-HGS during a live endoscopic demonstration.
Key Findings:
Technical success was achieved in the placement of the repositionable PS.
Functional clinical success was defined by significant bilirubin reduction and improvement in liver dysfunction.
Adverse events were graded according to established lexicon.
Interpretation:
The repositionable PS shows promise in improving the safety and efficacy of EUS-HGS procedures.
Limitations:
Single-center study may limit generalizability.
Exclusion of certain patient groups may affect the applicability of results.
Conclusion:
The novel repositionable PS demonstrates effective performance in EUS-HGS, indicating the need for further investigation.
